Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Change in Cash (2016 - 2017)

Bone Biologics (BBLG) has disclosed Change in Cash for 2 consecutive years, with -$931700.0 as the latest value for Q4 2017.

  • On a quarterly basis, Change in Cash fell 1273.01% to -$931700.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $69904.0, a 114.13% increase, with the full-year FY2025 number at $2.0 million, up 572.96% from a year prior.
  • Change in Cash was -$931700.0 for Q4 2017 at Bone Biologics, down from $838965.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $3.1 million in Q1 2016 to a low of -$2.0 million in Q2 2016.